
                                SEQUENCE LISTING

<110> The General Hospital Corporation

<120> THERAPEUTIC NANOPARTICLES AND METHODS OF
  USE THEREOF

<130> 29539-0035WO1

<150> US 61/510,563       
<151> 2011-07-22  

<160> 20

<170> FastSEQ for Windows Version 4.0

<210> 1
<211> 23
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic nucleotide

<400> 1
atgggacatc ttggcttaaa cac                                         23

<210> 2
<211> 22
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic nucleotide

<400> 2
tgtctaagct aagatcccct ta                                          22

<210> 3
<211> 23
<212> RNA
<213> Homo sapiens

<400> 3
uacccuguag aaccgaauuu gug                                         23

<210> 4
<211> 22
<212> RNA
<213> Homo sapiens

<400> 4
acagauucga uucuagggga au                                          22

<210> 5
<211> 22
<212> RNA
<213> Homo sapiens

<400> 5
ucccugagac ccuaacuugu ga                                          22

<210> 6
<211> 22
<212> RNA
<213> Homo sapiens

<400> 6
ucccugagac ccuaacuugu ga                                          22

<210> 7
<211> 22
<212> RNA
<213> Homo sapiens

<400> 7
ucccugagac ccuaacuugu ga                                          22

<210> 8
<211> 22
<212> RNA
<213> Homo sapiens

<400> 8
ucacaaguca ggcucuuggg ac                                          22

<210> 9
<211> 22
<212> RNA
<213> Homo sapiens

<400> 9
cauugcacuu gucucggucu ga                                          22

<210> 10
<211> 21
<212> RNA
<213> Homo sapiens

<400> 10
aggcggagac uugggcaauu g                                           21

<210> 11
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Targeting peptide

<400> 11
Asn Tyr Leu His Asn His Pro Tyr Gly Thr Val Gly
 1               5                  10          


<210> 12
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Targeting peptide

<400> 12
Ser Asn Pro Phe Ser Lys Pro Tyr Gly Leu Thr Val
 1               5                  10          


<210> 13
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Targeting peptide

<400> 13
Gly Leu His Glu Ser Thr Phe Thr Gln Arg Arg Leu
 1               5                  10          


<210> 14
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Targeting peptide

<400> 14
Tyr Pro His Tyr Ser Leu Pro Gly Ser Ser Thr Leu
 1               5                  10          


<210> 15
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Targeting peptide

<400> 15
Ser Ser Leu Glu Pro Trp His Arg Thr Thr Ser Arg
 1               5                  10          


<210> 16
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Targeting peptide

<400> 16
Leu Pro Leu Ala Leu Pro Arg His Asn Ala Ser Val
 1               5                  10          


<210> 17
<211> 22
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic nucleotide

<400> 17
gtgtaacacg tctatacgcc ca                                          22

<210> 18
<211> 23
<212> DNA
<213> Artificial Sequence

<220> 
<223> Synthetic nucleotide

<400> 18
cacaaattcg gttctacagg gta                                         23

<210> 19
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Targeting peptide

<400> 19
Ala Arg Arg Arg Arg Arg Arg Arg Cys
 1               5                  


<210> 20
<211> 110
<212> RNA
<213> Homo sapiens

<400> 20
ccagagguug uaacguuguc uauauauacc cuguagaacc gaauuugugu gguauccgua 60
uagucacaga uucgauucua ggggaauaua uggucgaugc aaaaacuuca            110
